Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
26 03 2019
Historique:
received: 04 10 2018
accepted: 09 02 2019
entrez: 24 3 2019
pubmed: 25 3 2019
medline: 28 3 2020
Statut: ppublish

Résumé

Nucleophosmin (

Identifiants

pubmed: 30902805
pii: bloodadvances.2018026989
doi: 10.1182/bloodadvances.2018026989
pmc: PMC6436014
doi:

Substances chimiques

NPM1 protein, human 0
Nuclear Proteins 0
Nucleophosmin 117896-08-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

922-933

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Informations de copyright

© 2019 by The American Society of Hematology.

Références

N Engl J Med. 2013 Jul 11;369(2):111-21
pubmed: 23841729
Ann Hematol. 2016 Dec;95(12):1931-1942
pubmed: 27696203
Leukemia. 2015 Feb;29(2):269-78
pubmed: 25179729
Cancer. 2007 Mar 15;109(6):1133-7
pubmed: 17315156
Blood. 2001 Aug 1;98(3):885-7
pubmed: 11468194
Blood. 2012 Sep 20;120(12):2454-65
pubmed: 22740453
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Mod Pathol. 2013 Jun;26(6):751-61
pubmed: 23307061
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Blood. 2011 Jan 27;117(4):1109-20
pubmed: 21030560
Lancet Oncol. 2009 Mar;10(3):223-32
pubmed: 19230772
Am J Clin Pathol. 2011 Jan;135(1):62-9
pubmed: 21173125
Cancer Cell. 2018 Sep 10;34(3):499-512.e9
pubmed: 30205049
Haematologica. 2010 Sep;95(9):1473-80
pubmed: 20421268
Blood. 2007 Feb 1;109(3):874-85
pubmed: 17008539
Leukemia. 2011 Jul;25(7):1147-52
pubmed: 21494260
Blood. 2014 Oct 23;124(17):2705-12
pubmed: 25224413
N Engl J Med. 2016 Nov 24;375(21):2023-2036
pubmed: 27959731
Blood. 2006 Dec 15;108(13):4146-55
pubmed: 16926285
Haematologica. 2018 Oct;103(10):e455-e457
pubmed: 29748442
J Clin Oncol. 2009 Oct 1;27(28):4747-53
pubmed: 19720919
Cancer. 2006 Apr 15;106(8):1794-803
pubmed: 16532500
Leuk Lymphoma. 2015;56(11):3222-6
pubmed: 25813079
Clin Cancer Res. 2015 Apr 1;21(7):1614-20
pubmed: 25609058
Cancer. 2009 Dec 15;115(24):5746-51
pubmed: 19795507
Am J Hematol. 2016 Dec;91(12):1239-1245
pubmed: 27643573
Leuk Res. 2015 Dec;39(12):1367-74
pubmed: 26547258
Expert Rev Mol Diagn. 2016;16(4):461-72
pubmed: 26765348
Blood. 2015 May 28;125(22):3455-65
pubmed: 25795919
Blood. 2006 Jul 15;108(2):419-25
pubmed: 16609072
Eur J Haematol. 2016 Jan;96(1):65-71
pubmed: 25809997
Cancer Cell. 2011 Jan 18;19(1):138-52
pubmed: 21251617
Blood. 2012 Sep 6;120(10):2076-86
pubmed: 22753872
Leukemia. 2018 Jun;32(6):1338-1348
pubmed: 29563537
Oncotarget. 2016 Mar 22;7(12):14172-87
pubmed: 26871476
Blood. 1997 Mar 15;89(6):2079-88
pubmed: 9058730

Auteurs

Guillermo Montalban-Bravo (G)

Department of Leukemia and.

Rashmi Kanagal-Shamanna (R)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Koji Sasaki (K)

Department of Leukemia and.

Keyur Patel (K)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Irene Ganan-Gomez (I)

Department of Leukemia and.

Elias Jabbour (E)

Department of Leukemia and.

Tapan Kadia (T)

Department of Leukemia and.

Farhad Ravandi (F)

Department of Leukemia and.

Courtney DiNardo (C)

Department of Leukemia and.

Gautham Borthakur (G)

Department of Leukemia and.

Marina Konopleva (M)

Department of Leukemia and.

Rami S Komrokji (RS)

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Amy DeZern (A)

Department of Hematology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and.

Teodora Kuzmanovic (T)

Department of Hematology and Medical Oncology Research, Cleveland Clinic, Cleveland, OH.

Jaroslaw Maciejewski (J)

Department of Hematology and Medical Oncology Research, Cleveland Clinic, Cleveland, OH.

Sherry Pierce (S)

Department of Leukemia and.

Simona Colla (S)

Department of Leukemia and.

Mikkael A Sekeres (MA)

Department of Hematology and Medical Oncology Research, Cleveland Clinic, Cleveland, OH.

Hagop Kantarjian (H)

Department of Leukemia and.

Carlos Bueso-Ramos (C)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Guillermo Garcia-Manero (G)

Department of Leukemia and.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH